Question · asked by 1 review

Antioxidants (lycopene, curcumin, Oxitard) vs Placebo or no active treatment: Difficulty in swallowing (participant-reported proxy)

Population
People of any age with a confirmed diagnosis, by clinical examination and biopsy, of oral submucous fibrosis (OSF)
Intervention
Antioxidants (lycopene, curcumin, Oxitard)
Comparison
Placebo or no active treatment
Outcome
Difficulty in swallowing (participant-reported proxy)

Antioxidants (lycopene, curcumin, Oxitard) led to lower difficulty in swallowing (participant-reported proxy) compared with placebo or no active treatment; GRADE not reported.

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
Antioxidants (lycopene, curcumin, Oxitard) vs Placebo or no active treatment
Difficulty in swallowing (participant-reported proxy) · People of any age with a confirmed diagnosis, by clinical examination and biopsy, of oral submucous fibrosis (OSF)
Antioxidants (lycopene, curcumin, Oxitard) led to lower difficulty in swallowing (participant-reported proxy) compared with placebo or no active treatment; GRADE not reported.
Interventions for managing oral submucous fibrosis (2024) · Cochrane All outcomes
OR 0.24 [0.10, 0.60]2 studies · 220 participantsGRADE not reported

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Interventions for managing oral submucous fibrosis
2024 · Cochrane All outcomes
2022-09Not listedNot assessed
How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.